StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Surgery Partners (SGRY) PT Lowered to $17 at TD Cowen
May 8, 2026 8:23 AM
TD Cowen analyst Ryan Langston lowered the price target on Surgery Partners (NASDAQ:
SGRY
) to $17.00 (from $20.00) while maintaining a Buy rating.
Categories
Analyst PT Change